STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Results of Operations and Financial ConditionItem 2.02.Results of Operations and Financial Condition.
Press Release (amended) dated November 9, 2017 issued by STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc. ExhibitEX-99.1 2 exhibit_99-1.htm STRATA PRESS RELEASE DATED NOVEMBER 9,…To view the full exhibit click
About STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN)
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company’s technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.